Overview

Safety Study of A-101 Topical Solution for the Treatment of Common Warts

Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts
Phase:
Phase 3
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Hydrogen Peroxide
Pharmaceutical Solutions